ArticleAlzheimer's & dementia (New York, N. Y.)2018

Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease.

Bjørn-Eivind Kirsebom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.